Efficacy and Safety of Atropine 0.01% for Pediatric Control: A Meta-analysis
Introduction: Low-dose atropine (0.01%) has a promising pharmacological effect for slowing pediatric myopia progression. Yet, its specific efficacy and safety profile require ongoing evaluation. Methods: Following PRISMA guidelines and a PROSPERO registered protocol, this systematic review and meta-analysis analyzed ra...